Antimicrobial drug use and resistance in Europe

Emerging Infectious Diseases

Volumn 14, Issue 11, 2008, Pages 1722-1730

  Van De Sande Bruinsma, Nienke ^a   Grundmann, Hajo ^a,b   Verloo, Didier ^c   Tiemersma, Edine ^a   Monen, Jos ^a   Goossens, Herman ^d,e   Ferech, Matus ^d   Mittermayer, H ^e   Metz, S ^e   Koller, W ^e   Hendrickx, E ^e   Markova, B ^e   Tambic Andrasevic, A ^e   Francetic, Igor ^e   Kalenic, S ^e   Bagatzouni, D ^e   Dvorak, P ^e   Urbaskova, P ^e   Monnet, D ^e   Anker Nielsen, A ^e   Naaber, P ^e   Huovinen, P ^e   Paakkari, P ^e   Lyytikainen, O ^e   Nissinen, A ^e   Maugendre, P ^e   Guillemot, D ^e   Coignard, B ^e   Jarlier, V ^e   Kern, W ^e   Schroeder, H ^e   Witte, W ^e   Heckenbach, K ^e   Giamarellou, H ^e   Antoniadou, A ^e   Tsakris, A ^e   Vatopoulos, A ^e   Ternak, G ^e   Fuzi, M ^e   Kristinsson, K ^e   Smyth, E ^e   Cunney, R ^e   Igoe, D ^e   Murphy, O ^e   Raz, R ^e   Cornaglia, G ^e   Pantosti, A ^e   D'Ancona, P ^e   Berzina, S ^e   Balode, A ^e   Valenteliene, R ^e   Miciulevicience, J ^e   Hemmer, R ^e   Bruch, M ^e   Borg, M ^e   Zarb, P ^e   Janknegt, R ^e   Filius, M ^e   De Neeling, H ^e   Tiemermsa, E ^e   Degener, J ^e   Salvesen Blix, H ^e   Hoiby, A ^e   Simonsen, G ^e   Hryniewicz, W ^e   Grzesiowski, P ^e   Caldeira, L ^e   Canica, M ^e   Codita, I ^e   Foltan, V ^e   Tesar, T ^e   Langsadl, L ^e   Cizman, M ^e   Mueller Premru, M ^e   Kolman, J ^e   Campos, J ^e   Baquero, F ^e   Cars, O ^e   Skoog, G ^e   Liljequist, B ^e   Kahlmeter, G ^e   Unal, S ^e   Gur D ^e   Davey, P ^e   Johnson, A ^e   Hill, R ^e   Hughes, H ^e   Coyne, M ^e   more..

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e Centre for Infectious Diseases Epidemiology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; LINCOSAMINE DERIVATIVE; MACROLIDE; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; STREPTOGRAMIN DERIVATIVE;

AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG USE; ECOLOGY; ESCHERICHIA COLI; EUROPE; HUMAN; PATHOGENESIS; STREPTOCOCCUS PNEUMONIAE;

EID: 55549120231     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1411.070467     Document Type: Article

References (29)

1. Rammelkamp M. Resistance of Staphylococcus aureus to the action of penicillin. Proc Soc Exp Biol Med. 1942;51:386-9.
2. Felmingham D, White AR, Jacobs MR, Appelbaum PC, Poupard J, Miller LA, et al. The Alexander Project: the benefits from a decade of surveillance. J Antimicrob Chemother. 2005;56(Suppl 2):ii3-ii21. DOI: 10.1093/jac/dki297
3. Jones RN. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin Respir Crit Care Med. 2003;24:121-34. DOI: 10.1055/s-2003-37923
4. Mackenzie FM, Bruce J, Van Looveren M, Cornaglia G, Gould IM, Goossens H. Antimicrobial susceptibility testing in European hospitals: report from the ARPAC study. Clin Microbiol Infect. 2006;12:1185-92. DOI: 10.1111/j.1469-0691. 2006.01549.x
5. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis. 2007;57:7-13.
6. Finch R, Hunter PA. Antibiotic resistance - action to promote new technologies: report of an EU intergovernmental conference held in Birmingham, UK, 12-13 December 2005. J Antimicrob Chemother. 2006;58(Suppl 1):i3-22. DOI: 10.1093/jac/dkl373
7. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H. European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol. 2004;58:419-28. DOI: 10.1111/j.1365-2125.2004.02164.x
8. Bronzwaer SL, Goettsch W, Olsson-Liljequist B, Wale MC, Vatopoulos AC, Sprenger MJ. European Antimicrobial Resistance Surveillance System (EARSS): objectives and organisation. Euro Surveill. 1999;4:41-4.
9. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother. 2006;58:401-7. DOI: 10.1093/jac/dkl188
10. World Health Organization. The anatomical therapeutic chemical classification system with defined daily doses (AT/DDD). Oslo: The Organization; 2005.
11. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H. Hospital consumption of antibiotics in 15 European countries: results of the ESAC retrospective data collection (1997-2002). J Antimicrob Chemother. 2006;58:159-67. DOI: 10.1093/jac/dkl147
12. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a crossnational database study. Lancet. 2005;365:579-87.
13. EARSS management team. EARSS annual report 2005. Bilthoven (the Netherlands): National Institute for Public Health and the Environment; 2006.
14. EARSS Management Team. EARSS manual 2005 [cited 2006 Nov 30]. Available from http://www.rivm.nl/earss/Images/Earss%20manual2005_tcm61-21261.pdf
15. Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Odenholt I, et al. European Committee on Antimicrobial Susceptibility Testing (EUCAST) technical notes on antimicrobial susceptibility testing. Clin Microbiol Infect. 2006;12:501-3. DOI: 10.1111/j.1469-0691.2006.01454.x
16. Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis. 2004;10:1627-34.
17. Bruinsma N, Kristinsson KG, Bronzwaer S, Schrijnemakers P, Degener J, Tiemersma E, et al. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother. 2004;54:1045-50. DOI: 10.1093/jac/dkh458
18. Bronzwaer S, Buchholz U, Courvalin P, Snell J, Cornaglia G, de Neeling A, et al. Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS). J Antimicrob Chemother. 2002;50:953-64. DOI: 10.1093/jac/dkf231
19. Lipsitch M. The rise and fall of antimicrobial resistance. Trends Microbiol. 2001;9:438-44. DOI: 10.1016/S0966-842X(01)02130-8
20. Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8:278-82.
21. Charpentier E, Tuomanen E. Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect. 2000;2:1855-64. DOI: 10.1016/S1286-4579(00)01345-9
22. Chenia HY, Pillay B, Pillay D. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens. J Antimicrob Chemother. 2006;58:1274-8. DOI: 10.1093/jac/dkl404
23. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A. 1999;96:1152-6. DOI: 10.1073/pnas.96.3. 1152
24. Enne VI, Livermore DM, Stephens P, Hall LM. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet. 2001;357:1325-8. DOI: 10.1016/S0140-6736(00)04519-0
25. Garcia-Rey C, Bouza E, Aguilar L, Garcia-de-Lomas J, Baquero F. Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain. Int J Antimicrob Agents. 2003;22:541-4. DOI: 10.1016/S0924-8579(03) 00239-5
26. Moellering RC Jr, Craig W, Edmond M, Farrell DJ, Ferraro MJ, File TM Jr, et al. Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae. J Chemother. 2002;14(Suppl 3):42-56. DOI: 10.1159/000063722
27. Perrin M, Donnio PY, Heurtin-Lecorre C, Travert MF, Avril JL. Comparative antimicrobial resistance and genomic diversity of Escherichia coli isolated from urinary tract infections in the community and in hospitals. J Hosp Infect. 1999;41:273-9. DOI: 10.1053/jhin.1998.0521
28. Harbarth S, Albrich W, Brun-Buisson C. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis. 2002;8:1460-7.
29. Steinke D, Davey P. Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clin Infect Dis. 2001;33(Suppl 3):S193-205. DOI: 10.1086/321848